DCP Director Dealings Bearish
DIS-CHEM PHARMACIES LIMITED - Dealing in Securities by an Associate of a Director
Dis-Chem Pharmacies Limited
Free preview
What this filing means
An associate of director Stanley Goetsch sold R11.18 million worth of Dis-Chem shares on-market near its 52-week high, signaling potential near-term valuation exhaustion.
Bull case
- The transaction demonstrates strong corporate governance and compliance with JSE Listings Requirements and Dis-Chem's internal share dealings policy.
- The sale was executed at a robust price point of R38.0008, reflecting a strong market valuation and potentially representing prudent portfolio rebalancing by the associate.
Bear case
- An associate of director Stanley Goetsch (Stansh Proprietary Limited) disposed of shares worth R11.18 million on-market.
Unlock the full analysis
Free during launch. Sign in to read the complete breakdown.
- Full bull / bear breakdown
- Decision framework
- Citations & sources
- Price autopsy
Related filings
More from DCP
- DIS-CHEM PHARMACIES LIMITED - Distribution of Integrated Annual Report; Notice of Annual General Meeting; and B-BBEE Annual Compliance Report
- DIS-CHEM PHARMACIES LIMITED - Audited Annual Consolidated Results for the twelve months ended 28 February 2026 and dividend declaration
- DIS-CHEM PHARMACIES LIMITED - Directorate Change
- DIS-CHEM PHARMACIES LIMITED - Dealings in securities
- DIS-CHEM PHARMACIES LIMITED - Dealing in Securities by an Associate of a Director
Other Director Dealings
- ISOASP ISOTOPES INC - Form 144 Report of Proposed Sale of Securities
- SSWSIBANYE STILLWATER LIMITED - Dealings in securities by Executive Director
- OPAOPTASIA LIMITED - Dealing In Securities By A Director And An Associate Of A Director
- BRAIT INVESTMENT HOLDINGS LIMITED - Dealings in securities
- VODVODACOM GROUP LIMITED - Sale of vested conditional and forfeitable shares